Morbus Osler
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (NCT01314274) | Medical University of Vienna | 2011-03-01 |
Track Morbus Osler automatically
Every clearance here is in the API, with alerts when new ones post.